Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
15.73
-0.36 (-2.24%)
At close: Mar 28, 2025, 4:00 PM
15.30
-0.44 (-2.77%)
Pre-market: Mar 31, 2025, 9:02 AM EDT

Arcutis Biotherapeutics Statistics

Total Valuation

ARQT has a market cap or net worth of $1.87 billion. The enterprise value is $1.75 billion.

Market Cap 1.87B
Enterprise Value 1.75B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

ARQT has 118.64 million shares outstanding. The number of shares has increased by 74.53% in one year.

Current Share Class 118.64M
Shares Outstanding 118.64M
Shares Change (YoY) +74.53%
Shares Change (QoQ) +0.50%
Owned by Insiders (%) 1.89%
Owned by Institutions (%) 84.02%
Float 85.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.68
Forward PS 6.07
PB Ratio 11.77
P/TBV Ratio 12.60
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.90
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.70.

Current Ratio 4.15
Quick Ratio 3.72
Debt / Equity 0.70
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.73

Financial Efficiency

Return on equity (ROE) is -113.76% and return on invested capital (ROIC) is -28.52%.

Return on Equity (ROE) -113.76%
Return on Assets (ROA) -23.25%
Return on Invested Capital (ROIC) -28.52%
Return on Capital Employed (ROCE) -47.93%
Revenue Per Employee $574,684
Profits Per Employee -$409,471
Employee Count 342
Asset Turnover 0.57
Inventory Turnover 1.38

Taxes

In the past 12 months, ARQT has paid $647,000 in taxes.

Income Tax 647,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +64.03% in the last 52 weeks. The beta is 1.49, so ARQT's price volatility has been higher than the market average.

Beta (5Y) 1.49
52-Week Price Change +64.03%
50-Day Moving Average 14.00
200-Day Moving Average 11.38
Relative Strength Index (RSI) 53.83
Average Volume (20 Days) 2,584,929

Short Selling Information

The latest short interest is 15.11 million, so 12.73% of the outstanding shares have been sold short.

Short Interest 15.11M
Short Previous Month 19.77M
Short % of Shares Out 12.73%
Short % of Float 17.72%
Short Ratio (days to cover) 6.95

Income Statement

In the last 12 months, ARQT had revenue of $196.54 million and -$140.04 million in losses. Loss per share was -$1.16.

Revenue 196.54M
Gross Profit 177.41M
Operating Income -128.40M
Pretax Income -214.05M
Net Income -140.04M
EBITDA -125.80M
EBIT -128.40M
Loss Per Share -$1.16
Full Income Statement

Balance Sheet

The company has $227.96 million in cash and $110.59 million in debt, giving a net cash position of $117.37 million or $0.99 per share.

Cash & Cash Equivalents 227.96M
Total Debt 110.59M
Net Cash 117.37M
Net Cash Per Share $0.99
Equity (Book Value) 157.54M
Book Value Per Share 1.34
Working Capital 254.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.16 million and capital expenditures -$143,000, giving a free cash flow of -$112.30 million.

Operating Cash Flow -112.16M
Capital Expenditures -143,000
Free Cash Flow -112.30M
FCF Per Share -$0.95
Full Cash Flow Statement

Margins

Gross margin is 90.27%, with operating and profit margins of -65.33% and -71.25%.

Gross Margin 90.27%
Operating Margin -65.33%
Pretax Margin -70.92%
Profit Margin -71.25%
EBITDA Margin -64.01%
EBIT Margin -65.33%
FCF Margin n/a

Dividends & Yields

ARQT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -74.53%
Shareholder Yield -74.53%
Earnings Yield -7.50%
FCF Yield -6.02%

Analyst Forecast

The average price target for ARQT is $18.80, which is 19.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.80
Price Target Difference 19.52%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 34.35%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ARQT has an Altman Z-Score of -0.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.93
Piotroski F-Score 3